Skip to Content

Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy (TNT)

In this MEDtalk from the ASCO GI conference, Dr. Yun Sung presents a study that evaluates survival outcomes for patients receiving TNT and gastric resection, including 203 patients, primarily treated with induction chemotherapy using 5-FU and oxaliplatin, followed by chemoradiation.

Yun Sung

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top